Skip Navigation

Johns Hopkins Malaria Research Institute

malaria-drug-development-and-resistance

Malaria Drug Development & Resistance
World Malaria Symposium - 25 April 2018

Please Save the Date! Registration is forthcoming.

The Johns Hopkins Malaria Research Institute is sponsoring a special malaria drug meeting to be held in conjunction with World Malaria Day, 25 April 2018 at the Bloomberg School of Public Health. The confirmed speakers are listed below:

Kelly Chibale, PhD - “PfPI4K inhibitor MMV048”
Department of Chemistry and IDM
University of Cape Town, South Africa

Thierry Diagana, PhD - “Whole cell screening and new leads”
Head of the Novartis Institute for Tropical Diseases (NITD)
Novartis Institute for BioMedical Research, Emeryville, California

Tawanda Gumbo, MD - “Pharmacokinetics and pharmacodynamics of tuberculosis drugs”
Professor and Director, Center for Infectious Diseases Research and Experimental Therapeutics
University of Texas Southwestern Medical Center

Kip Guy, PhD - “ATPase 4 inhibitor/SJ7333”
Dean, College of Pharmacy
University of Kentucky

Dennis Kyle, PhD -Atovaquone resistance”
Department of Infectious Diseases
College of Veterinary Medicine
The University of Georgia

Geoff McFadden, PhD - “Mosquito fitness of Plasmodium atovaquone resistance”
School of BioSciences
University of Melbourne, Australia

Steve Meshnick, MD, PhD - “Epidemiology and Mechanisms of Delayed Clearance with the Artemisinins”
Professor and Associate Chair
Director of Graduate Studies
Department of Epidemiology
University of North Carolina,Gillings School of Global Public Health

Margaret Phillips, PhD - Dihydroorotate dehydrogenase and DSM 265”
Professor and Chair
Department of Biochemistry
University of Texas Southwestern Medical Center

Leo Slater, PhD - “Early drug discovery animal models and the Survey of Antimalarial Drugs”
Historian
Washington, DC

Jianping Song, MD/PhD - “Mass drug administration on Comoros Island”
Guangzhou University of Chinese Medicine
People’s Republic of China

Giovani Traverso, MD, PhD - “Novel drug delivery (ivermectin)”
Associate Physician, Brigham and Women's Hospital
Assistant Professor, Harvard Medical School
Brigham and Women's Hospital
Department of Medicine

Thomas E. Wellems, MD, PhD - “Genetics of artemisinin delayed clearance phenotype”
Chief, Laboratory of Malaria and Vector Research (LMVR)
National Institute of Allergy and Infectious Diseases

Timothy Wells, FMedSci, PhD - “Drug targeting strategy”
Medicines for Malaria Venture
Geneva, Switzerland

Left image: Portrait of Eli Kennerly Marshall, Jr. who developed chloroquine to treat malaria. Photo credit: Chesney Medical Archives, Johns Hopkins Medical Institutions 
Right image: Malaria drug administration to infant. Photo credit: Gary Knight